Today's health news spans sleep and metabolism research, advances in IBD diagnostics, cognitive aging findings, emergency care optimization, cardiac surgery outcomes, drug regulation, medication safety warnings, and questions about weight-loss drug efficacy.

Sleep restriction over six weeks significantly increases weight gain and waist circumference in adults with cardiometabolic risk factors, linked to elevated leptin levels and reduced physical activity.

Implementation of intestinal ultrasound services for inflammatory bowel disease monitoring reduces endoscopy procedures by more than half, offering a less invasive diagnostic alternative.

Elderly adults aged 80+ who are 'super movers' with fast walking speeds demonstrate approximately 50% lower risk of cognitive impairment, despite showing similar Alzheimer's disease pathology to sedentary peers.

A new prediction model successfully identifies low-risk anaphylaxis cases in children who may safely avoid emergency department visits and additional epinephrine administration.

Bioprosthetic heart valves show favorable outcomes for pregnant women and childbearing-age patients undergoing aortic valve replacement compared to alternative valve options.

The DEA proposes scheduling concentrated synthetic 7-OH kratom products as Schedule I controlled substances while keeping most botanical kratom products outside the proposed ban.

The FDA strengthened safety warnings on alopecia areata treatment Litfulo, restricting its use to patients without suitable alternative treatment options available.

A network meta-analysis examining 19 weight-loss medications finds that most obesity drugs fail to improve cardiovascular health or quality of life measures in patients.